Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Anaemia drugs

MagazineApril 2009 (Vol. 20 Issue 1)Anaemia drugs

A major health alert has been issued on a class of drugs for treating anaemia

A major health alert has been issued on a class of drugs for treating anaemia. Known as 'erythropoiesis-stimulating agents', they can cause fatal cancers and heart problems.

In an earlier study of 1432 patients, 222 suffered heart problems, some of which were fatal.

America's drugs watchdog, the Food and Drug Administration (FDA), has issued a federal alert on these drugs, and will shortly be meeting to review their continued availability. In the meantime, the FDA is advising doctors to keep dosages of these drugs low.

These drugs are big business. In 2002, the latest year for which figures are available, global sales reached$8.1 billion (lb4.2 billion), an increase of 18 per cent over the previous year.

The drugs are routinely given to patients who are anaemic as a resultof chronic kidney failure, cancer, chemotherapy treatment, or HIV/AIDS (www.fda.gov/Medwatch/safety/2006/safety06.htm#drugs).


Symmetrel

Hiding behind junk science

You may also be interested in...

Sign up for free today

Sign up now to get your FREE 17-point Plan to Great Health

Free membership gives you access to our latest news reports, use of our community area, forums, blogs, readers' health tips and our twice-weekly
e-news letter.

WDDTY Recommends

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, cancer, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2016 WDDTY Publishing Ltd.
All Rights Reserved